GenScript Biotech Corporation has announced that its Board of Directors will convene a meeting on Saturday, 16 August 2025. The primary agenda includes the consideration and approval of the interim results for the six months ended 30 June 2025, the publication of these results, and the consideration of an interim dividend payment.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GenScript Biotech Corporation published the original content used to generate this news brief on August 04, 2025, and is solely responsible for the information contained therein.